Progress in drug-delivery systems in cardiovascular applications: stents, balloons and nanoencapsulation

Nanomedicine (Lond). 2022 Feb;17(5):325-347. doi: 10.2217/nnm-2021-0288. Epub 2022 Jan 21.

Abstract

Drug-delivery systems in cardiovascular applications regularly include the use of drug-eluting stents and drug-coated balloons to ensure sufficient drug transfer and efficacy in the treatment of cardiovascular diseases. In addition to the delivery of antiproliferative drugs, the use of growth factors, genetic materials, hormones and signaling molecules has led to the development of different nanoencapsulation techniques for targeted drug delivery. The review will cover drug delivery and coating mechanisms in current drug-eluting stents and drug-coated balloons, novel innovations in drug-eluting stent technologies and drug encapsulation in nanocarriers for delivery in vascular diseases. Newer technologies and advances in nanoencapsulation techniques, such as the use of liposomes, nanogels and layer-by-layer coating to deliver therapeutics in the cardiovascular space, will be highlighted.

Keywords: cardiovascular disease; coronary artery disease; drug delivery; drug-coated balloons; drug-eluting stents; peripheral artery disease.

Publication types

  • Review

MeSH terms

  • Cardiovascular Agents*
  • Coronary Restenosis*
  • Drug Delivery Systems
  • Drug-Eluting Stents*
  • Humans
  • Stents
  • Treatment Outcome

Substances

  • Cardiovascular Agents